These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

8897 related articles for article (PubMed ID: 22236355)

  • 21. FoxP3 and IDO in Canine Melanocytic Tumors.
    Porcellato I; Brachelente C; De Paolis L; Menchetti L; Silvestri S; Sforna M; Vichi G; Iussich S; Mechelli L
    Vet Pathol; 2019 Mar; 56(2):189-199. PubMed ID: 30381008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antigen expression in canine tissues, recognized by a monoclonal antibody generated against canine melanoma cells.
    Oliver JL; Wolfe LG
    Am J Vet Res; 1992 Jan; 53(1):123-8. PubMed ID: 1539903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic evaluation of Ki67 threshold value in canine oral melanoma.
    Bergin IL; Smedley RC; Esplin DG; Spangler WL; Kiupel M
    Vet Pathol; 2011 Jan; 48(1):41-53. PubMed ID: 21123859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant melanoma in 63 dogs (2001-2011): the effect of carboplatin chemotherapy on survival.
    Brockley LK; Cooper MA; Bennett PF
    N Z Vet J; 2013 Jan; 61(1):25-31. PubMed ID: 22913610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PCNA and Ki67 proliferation markers as criteria for prediction of clinical behaviour of melanocytic tumours in cats and dogs.
    Roels S; Tilmant K; Ducatelle R
    J Comp Pathol; 1999 Jul; 121(1):13-24. PubMed ID: 10373290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical characterization and evaluation of prognostic factors in canine oral melanomas with osteocartilaginous differentiation.
    Sánchez J; Ramirez GA; Buendia AJ; Vilafranca M; Martinez CM; Altimira J; Navarro JA
    Vet Pathol; 2007 Sep; 44(5):676-82. PubMed ID: 17846240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mast cells and angiogenesis in canine melanomas: malignancy and clinicopathological factors.
    Mukaratirwa S; Chikafa L; Dliwayo R; Moyo N
    Vet Dermatol; 2006 Apr; 17(2):141-6. PubMed ID: 16515657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanoma.
    Simpson RM; Bastian BC; Michael HT; Webster JD; Prasad ML; Conway CM; Prieto VM; Gary JM; Goldschmidt MH; Esplin DG; Smedley RC; Piris A; Meuten DJ; Kiupel M; Lee CC; Ward JM; Dwyer JE; Davis BJ; Anver MR; Molinolo AA; Hoover SB; Rodriguez-Canales J; Hewitt SM
    Pigment Cell Melanoma Res; 2014 Jan; 27(1):37-47. PubMed ID: 24128326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proliferation activity in oral and cutaneous canine melanocytic tumours: correlation with histological parameters, location, and clinical behaviour.
    Millanta F; Fratini F; Corazza M; Castagnaro M; Zappulli V; Poli A
    Res Vet Sci; 2002 Aug; 73(1):45-51. PubMed ID: 12208106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Developmental studies on melanoma of the skin and mouth mucosa of dogs].
    Frese K
    Vet Pathol; 1978 Jul; 15(4):461-73. PubMed ID: 695220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dysregulation of the Wnt/beta-catenin signaling pathway in canine cutaneous melanotic tumor.
    Han JI; Kim DY; Na KJ
    Vet Pathol; 2010 Mar; 47(2):285-91. PubMed ID: 20139375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Naturally occurring melanomas in dogs as models for non-UV pathways of human melanomas.
    Gillard M; Cadieu E; De Brito C; Abadie J; Vergier B; Devauchelle P; Degorce F; Dréano S; Primot A; Dorso L; Lagadic M; Galibert F; Hédan B; Galibert MD; André C
    Pigment Cell Melanoma Res; 2014 Jan; 27(1):90-102. PubMed ID: 24112648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical detection of melanoma-specific antigens in spontaneous canine melanoma.
    Sulaimon S; Kitchell B; Ehrhart E
    J Comp Pathol; 2002; 127(2-3):162-8. PubMed ID: 12354527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fascin, cortactin and survivin expression of melanocytic neoplasms and association with clinicopathological parameters and anatomic locations in Chinese people.
    Gao HW; Yu CP; Lee HS; Nieh S; Chiang CP; Wang WM; Jin JS
    Eur J Dermatol; 2010; 20(3):293-301. PubMed ID: 20400386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of leptin and iNOS in oral melanomas in dogs.
    Greene VR; Wilson H; Pfent C; Roethele J; Carwile J; Qin Y; Grimm E; Ellerhorst JA
    J Vet Intern Med; 2013; 27(5):1278-82. PubMed ID: 24033424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PDGFRs expression in dogs affected by malignant oral melanomas: correlation with prognosis.
    Iussich S; Maniscalco L; Di Sciuva A; Iotti B; Morello E; Martano M; Gattino F; Buracco P; De Maria R
    Vet Comp Oncol; 2017 Jun; 15(2):462-469. PubMed ID: 26833575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of tyrosinase expression in canine and equine melanocytic tumors.
    Phillips JC; Lembcke LM; Noltenius CE; Newman SJ; Blackford JT; Grosenbaugh DA; Leard AT
    Am J Vet Res; 2012 Feb; 73(2):272-8. PubMed ID: 22280389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant therapy for melanoma in dogs: results of randomized clinical trials using surgery, liposome-encapsulated muramyl tripeptide, and granulocyte macrophage colony-stimulating factor.
    MacEwen EG; Kurzman ID; Vail DM; Dubielzig RR; Everlith K; Madewell BR; Rodriguez CO; Phillips B; Zwahlen CH; Obradovich J; Rosenthal RC; Fox LE; Rosenberg M; Henry C; Fidel J
    Clin Cancer Res; 1999 Dec; 5(12):4249-58. PubMed ID: 10632367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumour-infiltrating lymphocytes in canine melanocytic tumours: An investigation on the prognostic role of CD3
    Porcellato I; Silvestri S; Menchetti L; Recupero F; Mechelli L; Sforna M; Iussich S; Bongiovanni L; Lepri E; Brachelente C
    Vet Comp Oncol; 2020 Sep; 18(3):370-380. PubMed ID: 31750993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical expression and prognostic significance of MAGE-A in canine oral malignant melanoma.
    Guillén A; Stiborova K; Ressel L; Blackwood L; Finotello R; Amores-Fuster I; Jama N; Killick D
    Res Vet Sci; 2021 Jul; 137():226-234. PubMed ID: 34023546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 445.